TriMas Corporation (TRS) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of TriMas Corporation stock $24.15, price $38.61, that is 37.5% below the price, quality 62 out of 100. Rating: strongly overvalued. Calculated from audited financials with 20 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range $19.74 – $44.94 · fair‑value band $20.15 – $30.83 · the $38.61 price screens above the $24.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.
Follow TriMas in your weekly email
Every Wednesday you see whether TriMas is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The company operates through Packaging and Specialty Products segments.
Show moreShow less
The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Aarts Packaging, Intertech, Omega Plastics, and Rapak brands.
The Specialty Products segment designs, manufactures, and distributes steel cylinders for use in transportation, storage, and dispensing of packaged and compressed gases under the Norris Cylinder brand. It sells its products through a direct sales force, third-party agents, and distributors.
The company was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
Stock analysis
TriMas Corporation (TRS) currently trades at $38.61, while our model-based Fair Value estimate is $24.15, 37% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $53.21 per share, and 4 of the 20 models we run sit above the $38.61 price.
Bear case: the Asset-Based group reads lowest at $6.14, and 16 of the 20 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $20.15 (bear) to $30.83 (bull), the price of $38.61 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Consumer Cyclical sector.
Mixed Growth: Spin-off in 2015: revenue and profit before it include the divested business. Growth is measured afresh from 2015.
TriMas Corporation reported revenue of $646M in FY2025 versus $857M in FY2021, a compound −6.8%/yr. Reported net income was $120M in FY2025, compounding +20.3%/yr from FY2021.
Key figures
Market cap $1.4B Small · P/E ratio 14.9 · P/S ratio 2.76 · EPS (TTM) $2.60 · Dividend yield 0.4% · Net margin 18.6% · Return on equity 9.4% · Return on assets (EBIT) 4.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 60 out of 100 (medium confidence).
What moves the price
The share trades about 14% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −24% fair-value upside, at −37%, TRS screens richer than that median.
Fair Value models
Bear$20.15Fair Value $24.15Bull$30.83
Price $38.61 · Downside -37.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($2.09 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, one officer or director bought shares worth $5,046, on Aug 12, 2026. Over the same period, one person sold shares worth $675,450.
BuyDaniel P TredwellDirector4× since Nov 12, 2025: 259 shares, avg. $37.62$9,750Aug 12, 2026
SaleHerbert K ParkerDirector15,000 shares at $45.03$675,450Jun 30, 202610b5-1 plan
SaleJodi F. RobinGeneral Counsel and Secretary5,000 shares at $41.30$206,520May 7, 2026
BuyJeffrey A FielkowDirector2,000 shares at $31.46$62,920Nov 11, 2025
Plus 3 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2015: revenue and profit before it include the divested business. Growth is measured afresh from 2015.
Revenue growth 1 year
+2.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.5%
Start year 2020 (pandemic). Over 10 years: −2.9% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
−28.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−29.1%
Dividend (yield on the price)0.4%
Per share before 2015divided by the spin-off factor 1.255
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11.1% vs 9.3%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 2%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 5.0%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+18.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +16.1% a year for the price.
News mood ⓘNews mood, the average tone of recent news (95 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaging & Containers · 259 stocks
Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score62 · Top 25%
Fair Value upside−37.5% · Below median
Profitability
Return on equity (12 months)9.4% · Above median
Return on assets8.1% · Top 25%
Net margin (12 months)135.2% · Top 25%
Operating margin (12 months)6.5% · Below median
Growth and dividend
Revenue growth (quarter YoY)−33.6% · Bottom 25%
Dividend yield (12 months)0.4% · Bottom 25%
Balance sheet
Debt / equity0.67× · Highest 25%
Valuation Multiplesvs Packaging & Containers median · lower = cheaper
P/E (12 months)14.9× · Cheaper than median
PEG1.94× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 24
FUTURE (revenue growth)0· sector 45
PAST (return on equity)37· sector 27
HEALTH (low debt)67· sector 92
DIVIDEND (yield)8· sector 47
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "TriMas Corporation Fair Value". https://www.fairvalue-calculator.com/stock/TRS
Frequently asked questions
Is TriMas Corporation (TRS) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $24.15 versus a price of $38.61, about 37% lower (overvalued).
What is the fair value of TRS?
Our model-based fair value for TriMas Corporation is $24.15 (as of Nov 7, 2026), built from audited fundamentals. The current price: $38.61.
What is the quality score of TRS?
TriMas Corporation has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for TriMas Corporation (TRS)?
Our model-based price target is the fair value of $24.15 (as of Nov 7, 2026) from 20 valuation models. Cautious scenario $20.15, optimistic scenario $30.83. It is a calculation from audited fundamentals, not an analyst target.
What is the TriMas Corporation stock forecast for 2026?
Our models put fair value at $24.15, about 37% lower versus a price of $38.61 (overvalued). Cautious scenario $20.15, optimistic scenario $30.83. The calculation is refreshed regularly with new filings.
What is the revenue of TriMas Corporation (TRS)?
TriMas Corporation reported trailing-twelve-month revenue of about $677M (latest available figure, as of Nov 7, 2026).
Does TriMas Corporation pay a dividend?
TriMas Corporation currently shows a dividend yield of 0.41% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of TriMas Corporation (TRS) and when is the ex-dividend date?
TriMas Corporation pays a dividend of $0.16 per share a year, a dividend yield of 0.4%. The last ex-dividend date was Nov 5, 2026. A dividend has been paid every year since at least 2021. The payout ratio is 75.6% of earnings (on adjusted earnings, reported 6.2%). Free cash flow covers the dividend 12.04 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into TriMas Corporation (TRS)?
For today's price to be fair in a discounted-cash-flow model, TriMas Corporation would have to grow free cash flow by +18.9 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -3.5 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of TRS use?
Our models discount TriMas Corporation at 10.1 %: a base by market capitalisation (small), damped by beta 0.61, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For TriMas Corporation that is +18.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has TriMas Corporation (TRS) delivered so far?
Over the past 5 years revenue at TriMas Corporation grew -3.5 % a year. The price currently implies free-cash-flow growth of +18.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of TriMas Corporation (TRS) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into TriMas Corporation (+18.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of TriMas Corporation (TRS)?
The free-cash-flow yield on the price is 4.94 %: that much free cash flow TriMas Corporation produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of TriMas Corporation (TRS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For TriMas Corporation it is $24.15 per share (as of Nov 7, 2026), against a price of $38.61. It is the blended result of 20 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is TriMas Corporation stock overvalued or undervalued in 2026?
As of Nov 7, 2026, TRS trades above its calculated fair value: price $38.61, fair value $24.15, a gap of about −37% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TRS?
No. The price is what the market pays today ($38.61); the fair value is what the company's own numbers justify ($24.15). For TriMas Corporation the two are $14.46 per share apart. That gap is exactly why we show both numbers side by side.
How much is TriMas Corporation worth?
The market values TriMas Corporation at about $1.4B (market capitalisation, as of Nov 7, 2026). Per share that is $38.61; our models calculate a fair value of $24.15 per share.
What do the bullish and bearish scenarios say about TRS?
Our models span a range for TriMas Corporation: cautious scenario $20.15, base $24.15, optimistic $30.83 per share (as of Nov 7, 2026, price $38.61). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of TRS?
TriMas Corporation trades at a price-to-earnings ratio of 14.9 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $24.15 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 160.9 (reported for FY2025: 13.1). Other multiples: PEG 1.9.
What is the PEG ratio of TRS?
The PEG ratio of TriMas Corporation is 1.94 (P/E divided by earnings growth, as of Nov 7, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of TriMas Corporation (TRS)?
Balance-sheet figures for TriMas Corporation (as of Nov 7, 2026): return on equity 9.4%, debt of 0.67 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is TRS from its 52-week high?
TriMas Corporation trades at $38.61, about 14% below its 52-week high of $44.94 and 25% above the low of $30.96 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $24.15 is for.
Which stocks are comparable to TriMas Corporation?
From the same area (Consumer Cyclical) we also value Smurfit Westrock Plc,, Packaging Corporation, Amcor plc, International Paper Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is TriMas Corporation stock attractive at the current price?
The data as of Nov 7, 2026: price $38.61, calculated fair value $24.15 (−37%), Quality Score 62/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TRS calculated?
We run TriMas Corporation through 20 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $24.15 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. TriMas Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of TriMas Corporation (TRS)?
The closing price on Nov 6, 2026 was $38.61. Our model-based fair value is $24.15, about 37% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with TriMas Corporation right now?
The price sits above even our optimistic bull case ($30.83). The favourable scenario is already priced in. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of TriMas Corporation
How large is the market capitalisation of TriMas Corporation (TRS)?
The market capitalisation of TriMas Corporation is $1.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of TriMas Corporation (TRS)?
The price-to-sales ratio of TriMas Corporation is 2.76 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of TriMas Corporation (TRS)?
Earnings per share at TriMas Corporation are $2.60 (price ÷ EPS = P/E 14.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of TriMas Corporation (TRS)?
The dividend yield of TriMas Corporation is 0.4% (payout 75.6%, on adjusted earnings, reported 6.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of TriMas Corporation (TRS)?
The net margin of TriMas Corporation is 18.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of TriMas Corporation (TRS)?
The return on equity (ROE) of TriMas Corporation is 9.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of TriMas Corporation (TRS)?
On an EBIT basis the return on assets of TriMas Corporation is 4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of TriMas Corporation (TRS)?
The operating margin of TriMas Corporation is 6.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at TriMas Corporation (TRS)?
Revenue at TriMas Corporation is growing −33.6% versus a year earlier (3y avg −9.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at TriMas Corporation (TRS)?
Earnings per share at TriMas Corporation are growing +133% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does TriMas Corporation (TRS) carry?
The net debt of TriMas Corporation is $475M (fiscal year 2025, ≈ 6.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch TriMas Corporation in the live analysis
One click puts TriMas Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 7, 2026